IDXX|IDEXX Laboratories Inc|Price:676.710|Chg%:-11.03

More Details of IDEXX Laboratories Inc Company

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Inc Info



Ticker SymbolIDXX

Company nameIDEXX Laboratories Inc

IPO dateJun 21, 1991

CEOEmerson (Andrew)

Number of employees11000

Security typeOrdinary Share

Fiscal year-endJun 21

AddressOne Idexx Drive

CityWESTBROOK

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code04092-2041

Phone12075560300

Websitehttps://www.idexx.com/

Ticker SymbolIDXX

IPO dateJun 21, 1991

CEOEmerson (Andrew)

Company Executives of IDEXX Laboratories Inc



Name

Name/Position

Position

Shareholding

Change

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+262.00%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+346.00%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+183.00%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+1447.00%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+262.00%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+1018.00%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+262.00%

Ms. Irene Chang Britt

Independent Director

208.00

--

Name

Name/Position

Position

Shareholding

Change

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+262.00%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+346.00%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+183.00%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+1447.00%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+262.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

CAG Diagnostics recurring revenue

873.27M

79.01%

IDEXX VetLab consumables

387.81M

35.09%

Reference laboratory diagnostic and consulting services

362.73M

32.82%

Rapid assay products

88.64M

8.02%

CAG Diagnostics capital - instruments

87.78M

7.94%

Other

-694.99M

-62.88%

By RegionUSD

Name

Revenue

Proportion

United States

705.04M

63.79%

Europe & Middle East & Africa (EMEA) (Region)

245.06M

22.17%

Asia Pacific

90.72M

8.21%

Canada

41.38M

3.74%

Latin America

23.04M

2.08%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

CAG Diagnostics recurring revenue

873.27M

79.01%

IDEXX VetLab consumables

387.81M

35.09%

Reference laboratory diagnostic and consulting services

362.73M

32.82%

Rapid assay products

88.64M

8.02%

CAG Diagnostics capital - instruments

87.78M

7.94%

Other

-694.99M

-62.88%

Shareholding Stats

Updated: Sun, Nov 16

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

12.41%

BlackRock Institutional Trust Company, N.A.

6.56%

State Street Investment Management (US)

4.41%

Fundsmith LLP

3.27%

Geode Capital Management, L.L.C.

3.13%

Other

70.23%

Shareholders

Proportion

The Vanguard Group, Inc.

12.41%

BlackRock Institutional Trust Company, N.A.

6.56%

State Street Investment Management (US)

4.41%

Fundsmith LLP

3.27%

Geode Capital Management, L.L.C.

3.13%

Other

70.23%

Shareholder Types

Shareholders

Proportion

Investment Advisor

53.99%

Investment Advisor/Hedge Fund

30.94%

Research Firm

3.98%

Pension Fund

2.91%

Bank and Trust

1.86%

Individual Investor

0.69%

Sovereign Wealth Fund

0.59%

Hedge Fund

0.54%

Family Office

0.50%

Other

4.01%

Institutional Shareholding



Updated: Thu, Jan 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

2344

75.90M

95.05%

-6.23M

2025Q3

2319

77.76M

97.19%

-4.03M

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

9.93M

12.43%

+85.73K

+0.87%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

5.24M

6.56%

-65.11K

-1.23%

Sep 30, 2025

State Street Investment Management (US)

3.52M

4.41%

-36.75K

-1.03%

Sep 30, 2025

Fundsmith LLP

2.61M

3.27%

-28.83K

-1.09%

Sep 30, 2025

Geode Capital Management, L.L.C.

2.50M

3.13%

+33.39K

+1.35%

Sep 30, 2025

Baron Capital Management, Inc.

1.88M

2.36%

-148.49K

-7.31%

Sep 30, 2025

Invesco Capital Management (QQQ Trust)

1.79M

2.24%

+114.65K

+6.84%

Dec 31, 2025

Principal Global Investors (Equity)

1.32M

1.65%

+187.97K

+16.67%

Sep 30, 2025

Polen Capital Management, LLC

1.13M

1.41%

-68.28K

-5.71%

Sep 30, 2025

Walter Scott & Partners Ltd.

1.12M

1.4%

+360.23K

+47.61%

Sep 30, 2025

Related ETFs



Updated: Tue, Dec 2

Name

Proportion

ProShares Pet Care ETF

9.4%

iShares U.S. Medical Devices ETF

4.42%

First Trust Water ETF

3.98%

SMI 3Fourteen Full-Cycle Trend ETF

3.9%

Nuveen ESG Mid-Cap Growth ETF

3.47%

Adaptive Core ETF

2.61%

First Trust S&P 500 Economic Moat Index ETF

2.25%

Acruence Active Hedge US Equity ETF

2.18%

Tema Durable Quality ETF

2.1%

Putnam Sustainable Future ETF

2.03%

ProShares Pet Care ETF

Proportion9.4%

iShares U.S. Medical Devices ETF

Proportion4.42%

First Trust Water ETF

Proportion3.98%

SMI 3Fourteen Full-Cycle Trend ETF

Proportion3.9%

Nuveen ESG Mid-Cap Growth ETF

Proportion3.47%

Adaptive Core ETF

Proportion2.61%

First Trust S&P 500 Economic Moat Index ETF

Proportion2.25%

Acruence Active Hedge US Equity ETF

Proportion2.18%

Tema Durable Quality ETF

Proportion2.1%

Putnam Sustainable Future ETF

Proportion2.03%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data